These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27148420)

  • 1. Overexpression of micro ribonucleic acid-591 inhibits cell proliferation and invasion of malignant pleural mesothelioma cells.
    Cheng S; Xu Y; Shi Z; Lin Y; Hoang CD; Zhang X
    Thorac Cancer; 2016 Apr; 7(3):340-7. PubMed ID: 27148420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.
    Reid G; Pel ME; Kirschner MB; Cheng YY; Mugridge N; Weiss J; Williams M; Wright C; Edelman JJ; Vallely MP; McCaughan BC; Klebe S; Brahmbhatt H; MacDiarmid JA; van Zandwijk N
    Ann Oncol; 2013 Dec; 24(12):3128-35. PubMed ID: 24148817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-1 induces growth arrest and apoptosis in malignant mesothelioma.
    Xu Y; Zheng M; Merritt RE; Shrager JB; Wakelee HA; Kratzke RA; Hoang CD
    Chest; 2013 Nov; 144(5):1632-1643. PubMed ID: 23828229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.
    Kubo T; Toyooka S; Tsukuda K; Sakaguchi M; Fukazawa T; Soh J; Asano H; Ueno T; Muraoka T; Yamamoto H; Nasu Y; Kishimoto T; Pass HI; Matsui H; Huh NH; Miyoshi S
    Clin Cancer Res; 2011 Aug; 17(15):4965-74. PubMed ID: 21673066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
    Jänne PA; Taffaro ML; Salgia R; Johnson BE
    Cancer Res; 2002 Sep; 62(18):5242-7. PubMed ID: 12234991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onconase mediated NFKβ downregulation in malignant pleural mesothelioma.
    Goparaju CM; Blasberg JD; Volinia S; Palatini J; Ivanov S; Donington JS; Croce C; Carbone M; Yang H; Pass HI
    Oncogene; 2011 Jun; 30(24):2767-77. PubMed ID: 21317924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells.
    Maki Y; Asano H; Toyooka S; Soh J; Kubo T; Katsui K; Ueno T; Shien K; Muraoka T; Tanaka N; Yamamoto H; Tsukuda K; Kishimoto T; Kanazawa S; Miyoshi S
    Anticancer Res; 2012 Nov; 32(11):4871-5. PubMed ID: 23155254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs dysregulation in human malignant pleural mesothelioma.
    Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
    J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice.
    Tabata C; Tabata R; Hirayama N; Yasumitsu A; Yamada S; Murakami A; Iida S; Tamura K; Terada T; Kuribayashi K; Fukuoka K; Nakano T
    Eur Respir J; 2009 Nov; 34(5):1159-67. PubMed ID: 19443527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells.
    Cioce M; Rutigliano D; Puglielli A; Fazio VM
    Cancer Drug Resist; 2022; 5(3):814-828. PubMed ID: 36176750
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma.
    Iwahori K; Serada S; Fujimoto M; Nomura S; Osaki T; Lee CM; Mizuguchi H; Takahashi T; Ripley B; Okumura M; Kawase I; Kishimoto T; Naka T
    Int J Cancer; 2011 Aug; 129(4):1005-17. PubMed ID: 20949562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional suppression of the miR-15/16 family by c-Myc in malignant pleural mesothelioma.
    Williams M; Cheng YY; Kirschner MB; Sarun KH; Schelch K; Winata P; McCaughan B; Kao S; Van Zandwijk N; Reid G
    Oncotarget; 2019 Jun; 10(41):4125-4138. PubMed ID: 31289611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MT1-MMP plays an important role in an invasive activity of malignant pleural mesothelioma cell.
    Doi T; Maniwa Y; Tanaka Y; Tane S; Hashimoto S; Ohno Y; Nishio W; Nishimura Y; Ohbayashi C; Okita Y; Hayashi Y; Yoshimura M
    Exp Mol Pathol; 2011 Feb; 90(1):91-6. PubMed ID: 20969861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
    Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
    Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
    Jagadeeswaran R; Ma PC; Seiwert TY; Jagadeeswaran S; Zumba O; Nallasura V; Ahmed S; Filiberti R; Paganuzzi M; Puntoni R; Kratzke RA; Gordon GJ; Sugarbaker DJ; Bueno R; Janamanchi V; Bindokas VP; Kindler HL; Salgia R
    Cancer Res; 2006 Jan; 66(1):352-61. PubMed ID: 16397249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathways.
    Williams M; Cheng YY; Phimmachanh M; Winata P; van Zandwijk N; Reid G
    Cancer Drug Resist; 2019; 2(4):1193-1206. PubMed ID: 35582270
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma.
    Amatya VJ; Mawas AS; Kushitani K; Mohi El-Din MM; Takeshima Y
    Int J Oncol; 2016 Apr; 48(4):1599-607. PubMed ID: 26820394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt2 as a new therapeutic target in malignant pleural mesothelioma.
    Mazieres J; You L; He B; Xu Z; Twogood S; Lee AY; Reguart N; Batra S; Mikami I; Jablons DM
    Int J Cancer; 2005 Nov; 117(2):326-32. PubMed ID: 15900580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
    Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
    PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen Suppresses the Growth of Malignant Pleural Mesothelioma Cells.
    Jennings CJ; Zainal N; Dahlan IM; Kay EW; Harvey BJ; Thomas W
    Anticancer Res; 2016 Nov; 36(11):5905-5913. PubMed ID: 27793915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.